Work

Prevalence and molecular susceptibility of Mycoplasma genitalium in KwaZulu-Natal population.

Year: 2021
Type: dissertation
Abstract: Background: Mycoplasma genitalium is a recently classified sexually transmitted pathogen associated \nwith causing urethritis and cervicitis, potentially causing reproductive complications. Mycoplasma \ngenitalium has been shown to develop resistance to the currently recommended drug regimens, namely, \nazithromycin used as first-line therapy and moxifloxacin (second-line). The resistance prevalence of M. \ngenitalium to the current treatment is diverse across the world. In South Africa, few studies have evaluated \nthe prevalence of resistance to azithromycin and other fluoroquinolones. This study was conducted to \nevaluate the presence of macrolide and fluoroquinolone-resistant gene mutations in a KwaZulu-Natal \npopulation infected with M. genitalium. \nMethods: Samples from the CAPRISA HIPPS cohort study were used for this analysis. Deoxyribonucleic \nacid was extracted from 100 stored M. genitalium positive self-collected vaginal swab samples. Real-time \nPCR was performed to confirm M. genitalium positivity. Genes associated with resistance to macrolides \n(23S rRNA, L4, L22) and fluoroquinolones (gryA) were sequenced and analysed. \nResults: All 100 samples were confirmed genotypically to be M. genitalium positive and were sequenced. \nFrom the 100 samples tested for M. genitalium, 73 were successful for 23S rRNA, 99 for L4, 91 for L22, \nand 80 for gryA. Of the seventy-three 23S rRNA sequences, five samples carried mutations associated with \nmacrolide resistance. A total of 12 mutations coding for macrolide resistance (5 for 23S, 4 for L4, and 3 \nfor L22) were identified following sequencing. The prevalence of resistance mutations to macrolides was \nthus 7% (5 of 73) for 23 S rRNA, 4% (4of 99) for L4, and 3% (3 of 91) for L22 protein. In the five samples \nthat harboured 23S rRNA gene mutation one had: A2071T, A2072C, A2072T, and two with A2072G \nmutation. L4 and L22 harboured silent mutations at positions: T327C, G429A, C438T, C438A, G81A, and \nC351T. In the 80 samples successful for gryA, six carried mutations with a prevalence of 8% (6/80 x100%). \nConclusion: Ongoing antimicrobial surveillance needs to be performed in our local populations as in our \nstudy we have seen the presence of mutations to macrolides and fluoroquinolones. This study was \nperformed on samples collected during the early stages of introducing azithromycin as the first-line regimen for M. genitalium infection. More current studies need to be performed at a later time point to evaluate the \nantimicrobial resistance burden in M. genitalium.
Author: Mvuna, Londeka Desire.
Language: English
Subfield: Microbiology
Open Access status: green
OpenAlex ID: W7014705932
Cites: 159
Cited by:
Related to: 10